Gary Ritten
Gynecology · Erie, PANPI 1437211307
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.
Across 120 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$276
- Novo Nordisk$224
- Lilly USA, LLC$154
- Amarin Pharma, Inc.$119
- Daiichi Sankyo Inc.$113
- Boehringer Ingelheim$112
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,134100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $276 |
| Novo Nordisk | 13 | $224 |
| Lilly USA, LLC | 9 | $154 |
| Amarin Pharma, Inc. | 9 | $119 |
| Daiichi Sankyo Inc. | 8 | $113 |
| Boehringer Ingelheim | 8 | $112 |
| Exact Sciences | 5 | $97 |
| Abbott | 5 | $94 |
| Amgen | 5 | $88 |
| Johnson & Johnson | 5 | $83 |
| GSK | 4 | $74 |
| Bayer | 4 | $71 |
| Dexcom, Inc. | 3 | $63 |
| Insulet Corporation | 3 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Pfizer | 2 | $37 |
| Pacira Therapeutics, Inc. | 2 | $35 |
| Biogen | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Mallinckrodt Enterprises LLC | 1 | $26 |
| Gilead | 2 | $25 |
| Lundbeck LLC | 1 | $24 |
| Seqirus USA Inc | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Myovant Sciences Inc. | 1 | $20 |
| Axonics, Inc. | 1 | $18 |
| UCB, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| Coopersurgical, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Organon | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$115
How this compares
$2,134 in reported general payments places this provider in the 75th percentile of 98 gynecology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 11 | $224 |
| Estradiol | 12 | $123 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Erie
- Jordan KlebanoffNewtown Square$187K
- Harry ReichShavertown$136K
- Gretchen MakaiYork$102K
- Karen TangBryn Mawr$96K
- Joseph TalvacchiaPhiladelphia$85K
- David ToubWyncote$41K
- David EvansCarlisle$30K
- Harold DavisScranton$22K
- Reneita RossPhiladelphia$8K
- Marydonna RavasioButler$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.